Copperwynd Financial, LLC Immunity Bio, Inc. Transaction History
Copperwynd Financial, LLC
- $330 Million
- Q3 2024
A detailed history of Copperwynd Financial, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Copperwynd Financial, LLC holds 10,087 shares of IBRX stock, worth $28,041. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,087
Previous 15,987
36.9%
Holding current value
$28,041
Previous $101,000
63.37%
% of portfolio
0.01%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding IBRX
# of Institutions
204Shares Held
70MCall Options Held
1.68MPut Options Held
1.31M-
Vanguard Group Inc Valley Forge, PA16.9MShares$47 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$31.8 Million0.0% of portfolio
-
State Street Corp Boston, MA8.65MShares$24.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.85MShares$10.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.25MShares$6.25 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.11B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...